Results 21 to 30 of about 301,311 (355)

Effects of stem cell factor on hypoxia-inducible factor 1 alpha accumulation in human acute myeloid leukaemia and LAD2 mast cells. [PDF]

open access: yesPLoS ONE, 2011
Stem cell factor (SCF) is a hematopoietic growth factor that exerts its activity by signalling through the tyrosine kinase receptor known as Kit or CD117.
Bernhard F Gibbs   +3 more
doaj   +1 more source

Chronic myeloid leukaemia presenting as acute small bowel gangrene: A case report

open access: yesJournal of Acute Disease, 2021
Rationale: Chronic myeloid leukaemia is a myeloproliferative disorder due to clonal hyperproliferation of myeloid cells within the bone marrow. It can present both pro- and anti-thrombotic states.
Jayabal Pandiaraja, Arumugam Shalini
doaj   +1 more source

Erythropoiesis in Murine Myeloid Leukaemia [PDF]

open access: greenBritish Journal of Cancer, 1970
Erythropoiesis during the development of myeloid leukaemia in mice was studied, using assay of radio-iron incorporation in blood, exorepopulation and autorepopulation techniques. These tests indicated a certain tendency of decreasing erythropoiesis during the leukaemic process due to declining numbers of the normal erthropoietic cell precursors.
T Tanaka
openalex   +5 more sources

Congenital Acute Myeloid Leukaemia with Pseudo-Chediak-Higashi Like Granules: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Congenital leukaemia is a very rare entity comprising 0.8% of all childhood leukaemias. Pseudo-Chediak-Higashi Anomaly (PCHA) in acute leukaemia is a rarely described entity. However, co-existence of congenital myeloid leukaemia with PCHA is a very rare
Vandana Puri   +3 more
doaj   +1 more source

COVID-19 in persons with chronic myeloid leukaemia

open access: yesLeukemia, 2020
We studied by questionnaire 530 subjects with chronic myeloid leukaemia (CML) in Hubei Province during the recent SARS-CoV-2 epidemic. Five developed confirmed ( N  = 4) or probable COVID-19 ( N  = 1).
Weiming Li   +41 more
semanticscholar   +1 more source

Acute myeloid leukaemia

open access: yesHematology, 2014
Acute myeloid leukaemia (AML) is a type of cancer of the part of the bone marrow that normally makes ‘myeloid’ cells.
Matthew Smith, Sandra Hassan
openaire   +3 more sources

Granulocytic sarcoma of the femur in a patient with acute megakaryoblastic leukaemia [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2011
Introduction. Granulocytic sarcoma, chloroma or myeloblastoma are observed in 3% to7% of acute myeloid leukaemia and represents localized tumour composed of collection of immature leukaemic cells. It appears most frequently in patients with M2, M4 and
Čolović Milica   +4 more
doaj   +1 more source

Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature

open access: yesCase Reports in Oncology, 2017
Natural killer (NK) cell lymphoblastic leukaemia/lymphoma is a rare haemopoietic tumour currently defined in the 2008 WHO classification under the category of acute leukaemias of ambiguous lineage.
Qanita Sedick   +4 more
doaj   +1 more source

Prediction of acute myeloid leukaemia risk in healthy individuals

open access: yesNature, 2018
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow ...
Sagi Abelson   +74 more
semanticscholar   +1 more source

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia

open access: yesCurrent Oncology Reports, 2020
Purpose of Review Acute myeloid leukaemia (AML) is a heterogeneous malignancy for which treatment options remain suboptimal. It is clear that a greater understanding of the biology of the AML niche will enable new therapeutic strategies to be developed ...
E. Ladikou   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy